SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-012724
Filing Date
2021-05-24
Accepted
2021-05-24 16:56:34
Documents
60
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 495686
2 ex10-1.htm EX-10.1 21830
3 ex31-1.htm EX-31.1 15466
4 ex31-2.htm EX-31.2 15492
5 ex32-1.htm EX-32.1 6748
6 ex32-2.htm EX-32.2 7150
7 image_001.jpg GRAPHIC 26397
  Complete submission text file 0001493152-21-012724.txt   3009994

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE mslp-20210331.xml EX-101.INS 410432
9 XBRL SCHEMA FILE mslp-20210331.xsd EX-101.SCH 32740
10 XBRL CALCULATION FILE mslp-20210331_cal.xml EX-101.CAL 54515
11 XBRL DEFINITION FILE mslp-20210331_def.xml EX-101.DEF 110037
12 XBRL LABEL FILE mslp-20210331_lab.xml EX-101.LAB 244884
13 XBRL PRESENTATION FILE mslp-20210331_pre.xml EX-101.PRE 191613
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53166 | Film No.: 21955761
SIC: 2834 Pharmaceutical Preparations